back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-08-20 11:30 Tx date 2024-08-16 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Johnson, Neil Allan
4 - Director of Issuer
Holder: Abinvest Corporation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,500
+50,000 vol $0.11 each |
330,000 | |
| Filed 2024-07-31 15:29 Tx date 2024-07-23 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Johnson, Neil Allan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
500,000 | |
| Filed 2022-10-04 16:00 Tx date 2022-09-26 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Johnson, Neil Allan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,000
+200,000 vol $0.10 each |
375,000 | |
| Filed 2022-07-20 16:20 Tx date 2022-07-18 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Johnson, Neil Allan
4 - Director of Issuer
Holder: Abinvest Corporation (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+250,000 vol $0.10 each |
280,000 | |
| Filed 2022-03-31 12:06 Tx date 2022-03-22 |
$ROZP
Rozdil Capital Corporation |
Johnson, Neil Allan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$12,500
+125,000 vol $0.10 each |
875,000 | |
| Filed 2022-03-31 12:04 Tx date 2022-03-22 |
$ROZP
Rozdil Capital Corporation |
Johnson, Neil Allan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-12,500
-125,000 vol $0.10 each |
0 | |
| Filed 2022-03-25 09:46 Tx date 2022-03-18 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Johnson, Neil Allan
4 - Director of Issuer
Holder: Abinvest Corporation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,320
+30,000 vol $0.144 each |
30,000 | |
| Filed 2022-03-25 09:43 Tx date 2021-06-14 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Johnson, Neil Allan
4 - Director of Issuer
Holder: Abinvest Corporation (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-07-16 11:09 Tx date 2021-07-14 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Johnson, Neil Allan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+175,000 vol |
175,000 | |
| Filed 2021-07-16 11:05 Tx date 2021-06-14 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Johnson, Neil Allan
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-07-16 11:02 Tx date 2021-06-14 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Johnson, Neil Allan
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
125,000 | ||
| Filed 2019-07-17 16:09 Tx date 2019-07-16 |
$ROZP
Rozdil Capital Corporation |
Johnson, Neil Allan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
125,000 | |
| Filed 2019-07-17 16:06 Tx date 2019-05-27 |
$ROZP
Rozdil Capital Corporation |
Johnson, Neil Allan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-11 13:28 Tx date 2019-05-27 |
$
Rozdil Capital Corporation |
Johnson, Neil Allan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
750,000 |